ALL KEYWORDS
Sarcoma Genomics
Related Specialists
Showing 3 of 23
Related Fact Sheets
Related Clinical Trials
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Study of Ivosidenib in Participants ≥18 Years of Age With Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
- Sarcoma Cancers
- Gender:All Genders
- Age:18 years and older
The SIGNAL Study
- Children's Health
- Respiratory System
Related News
Related Departments
Showing 3 of 25